[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Rare Disease CRO Service Supply, Demand and Key Producers, 2023-2029

December 2023 | 157 pages | ID: GDCD5F6DCD01EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Rare Disease CRO Service market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Rare disease CRO (Contract Research Organization) service refers to the specialized research and clinical trial services tailored to address the unique needs of drug development for rare diseases. These services may include clinical trial design, patient recruitment, regulatory support, and data analysis specifically focused on rare disease therapeutics.

This report studies the global Rare Disease CRO Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Rare Disease CRO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Rare Disease CRO Service that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Rare Disease CRO Service total market, 2018-2029, (USD Million)

Global Rare Disease CRO Service total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Rare Disease CRO Service total market, key domestic companies and share, (USD Million)

Global Rare Disease CRO Service revenue by player and market share 2018-2023, (USD Million)

Global Rare Disease CRO Service total market by Type, CAGR, 2018-2029, (USD Million)

Global Rare Disease CRO Service total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Rare Disease CRO Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Precision for Medicine, Orphan-Reach, Medpace, Parexel, PPD, Worldwide Clinical Trials, AllStripes, LabCorp and Novotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Rare Disease CRO Service market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Rare Disease CRO Service Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Rare Disease CRO Service Market, Segmentation by Type
  • Drug Development Strategy
  • Clinical Trial Management
Global Rare Disease CRO Service Market, Segmentation by Application
  • Cardiovascular
  • Neuroscience
  • Ophthalmology
  • Others
Companies Profiled:
  • Precision for Medicine
  • Orphan-Reach
  • Medpace
  • Parexel
  • PPD
  • Worldwide Clinical Trials
  • AllStripes
  • LabCorp
  • Novotech
  • Syneos Health
  • Vial
  • Machaon Diagnostics
  • Caidya
  • Simbec Orion
  • Linical
  • MMS
  • Veristat
  • Celero
  • Rho
  • PROMETRIKA
Key Questions Answered

1. How big is the global Rare Disease CRO Service market?

2. What is the demand of the global Rare Disease CRO Service market?

3. What is the year over year growth of the global Rare Disease CRO Service market?

4. What is the total value of the global Rare Disease CRO Service market?

5. Who are the major players in the global Rare Disease CRO Service market?
1 SUPPLY SUMMARY

1.1 Rare Disease CRO Service Introduction
1.2 World Rare Disease CRO Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Rare Disease CRO Service Total Market by Region (by Headquarter Location)
  1.3.1 World Rare Disease CRO Service Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Rare Disease CRO Service Market Size (2018-2029)
  1.3.3 China Rare Disease CRO Service Market Size (2018-2029)
  1.3.4 Europe Rare Disease CRO Service Market Size (2018-2029)
  1.3.5 Japan Rare Disease CRO Service Market Size (2018-2029)
  1.3.6 South Korea Rare Disease CRO Service Market Size (2018-2029)
  1.3.7 ASEAN Rare Disease CRO Service Market Size (2018-2029)
  1.3.8 India Rare Disease CRO Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Rare Disease CRO Service Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Rare Disease CRO Service Major Market Trends

2 DEMAND SUMMARY

2.1 World Rare Disease CRO Service Consumption Value (2018-2029)
2.2 World Rare Disease CRO Service Consumption Value by Region
  2.2.1 World Rare Disease CRO Service Consumption Value by Region (2018-2023)
  2.2.2 World Rare Disease CRO Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Rare Disease CRO Service Consumption Value (2018-2029)
2.4 China Rare Disease CRO Service Consumption Value (2018-2029)
2.5 Europe Rare Disease CRO Service Consumption Value (2018-2029)
2.6 Japan Rare Disease CRO Service Consumption Value (2018-2029)
2.7 South Korea Rare Disease CRO Service Consumption Value (2018-2029)
2.8 ASEAN Rare Disease CRO Service Consumption Value (2018-2029)
2.9 India Rare Disease CRO Service Consumption Value (2018-2029)

3 WORLD RARE DISEASE CRO SERVICE COMPANIES COMPETITIVE ANALYSIS

3.1 World Rare Disease CRO Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Rare Disease CRO Service Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Rare Disease CRO Service in 2022
  3.2.3 Global Concentration Ratios (CR8) for Rare Disease CRO Service in 2022
3.3 Rare Disease CRO Service Company Evaluation Quadrant
3.4 Rare Disease CRO Service Market: Overall Company Footprint Analysis
  3.4.1 Rare Disease CRO Service Market: Region Footprint
  3.4.2 Rare Disease CRO Service Market: Company Product Type Footprint
  3.4.3 Rare Disease CRO Service Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Rare Disease CRO Service Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Rare Disease CRO Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Rare Disease CRO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Rare Disease CRO Service Consumption Value Comparison
  4.2.1 United States VS China: Rare Disease CRO Service Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Rare Disease CRO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Rare Disease CRO Service Companies and Market Share, 2018-2023
  4.3.1 United States Based Rare Disease CRO Service Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Rare Disease CRO Service Revenue, (2018-2023)
4.4 China Based Companies Rare Disease CRO Service Revenue and Market Share, 2018-2023
  4.4.1 China Based Rare Disease CRO Service Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Rare Disease CRO Service Revenue, (2018-2023)
4.5 Rest of World Based Rare Disease CRO Service Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Rare Disease CRO Service Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Rare Disease CRO Service Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Rare Disease CRO Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Drug Development Strategy
  5.2.2 Clinical Trial Management
5.3 Market Segment by Type
  5.3.1 World Rare Disease CRO Service Market Size by Type (2018-2023)
  5.3.2 World Rare Disease CRO Service Market Size by Type (2024-2029)
  5.3.3 World Rare Disease CRO Service Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Rare Disease CRO Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Cardiovascular
  6.2.2 Neuroscience
  6.2.3 Ophthalmology
  6.2.4 Others
  6.2.5 Others
6.3 Market Segment by Application
  6.3.1 World Rare Disease CRO Service Market Size by Application (2018-2023)
  6.3.2 World Rare Disease CRO Service Market Size by Application (2024-2029)
  6.3.3 World Rare Disease CRO Service Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Precision for Medicine
  7.1.1 Precision for Medicine Details
  7.1.2 Precision for Medicine Major Business
  7.1.3 Precision for Medicine Rare Disease CRO Service Product and Services
  7.1.4 Precision for Medicine Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Precision for Medicine Recent Developments/Updates
  7.1.6 Precision for Medicine Competitive Strengths & Weaknesses
7.2 Orphan-Reach
  7.2.1 Orphan-Reach Details
  7.2.2 Orphan-Reach Major Business
  7.2.3 Orphan-Reach Rare Disease CRO Service Product and Services
  7.2.4 Orphan-Reach Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Orphan-Reach Recent Developments/Updates
  7.2.6 Orphan-Reach Competitive Strengths & Weaknesses
7.3 Medpace
  7.3.1 Medpace Details
  7.3.2 Medpace Major Business
  7.3.3 Medpace Rare Disease CRO Service Product and Services
  7.3.4 Medpace Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Medpace Recent Developments/Updates
  7.3.6 Medpace Competitive Strengths & Weaknesses
7.4 Parexel
  7.4.1 Parexel Details
  7.4.2 Parexel Major Business
  7.4.3 Parexel Rare Disease CRO Service Product and Services
  7.4.4 Parexel Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Parexel Recent Developments/Updates
  7.4.6 Parexel Competitive Strengths & Weaknesses
7.5 PPD
  7.5.1 PPD Details
  7.5.2 PPD Major Business
  7.5.3 PPD Rare Disease CRO Service Product and Services
  7.5.4 PPD Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 PPD Recent Developments/Updates
  7.5.6 PPD Competitive Strengths & Weaknesses
7.6 Worldwide Clinical Trials
  7.6.1 Worldwide Clinical Trials Details
  7.6.2 Worldwide Clinical Trials Major Business
  7.6.3 Worldwide Clinical Trials Rare Disease CRO Service Product and Services
  7.6.4 Worldwide Clinical Trials Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Worldwide Clinical Trials Recent Developments/Updates
  7.6.6 Worldwide Clinical Trials Competitive Strengths & Weaknesses
7.7 AllStripes
  7.7.1 AllStripes Details
  7.7.2 AllStripes Major Business
  7.7.3 AllStripes Rare Disease CRO Service Product and Services
  7.7.4 AllStripes Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 AllStripes Recent Developments/Updates
  7.7.6 AllStripes Competitive Strengths & Weaknesses
7.8 LabCorp
  7.8.1 LabCorp Details
  7.8.2 LabCorp Major Business
  7.8.3 LabCorp Rare Disease CRO Service Product and Services
  7.8.4 LabCorp Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 LabCorp Recent Developments/Updates
  7.8.6 LabCorp Competitive Strengths & Weaknesses
7.9 Novotech
  7.9.1 Novotech Details
  7.9.2 Novotech Major Business
  7.9.3 Novotech Rare Disease CRO Service Product and Services
  7.9.4 Novotech Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Novotech Recent Developments/Updates
  7.9.6 Novotech Competitive Strengths & Weaknesses
7.10 Syneos Health
  7.10.1 Syneos Health Details
  7.10.2 Syneos Health Major Business
  7.10.3 Syneos Health Rare Disease CRO Service Product and Services
  7.10.4 Syneos Health Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Syneos Health Recent Developments/Updates
  7.10.6 Syneos Health Competitive Strengths & Weaknesses
7.11 Vial
  7.11.1 Vial Details
  7.11.2 Vial Major Business
  7.11.3 Vial Rare Disease CRO Service Product and Services
  7.11.4 Vial Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Vial Recent Developments/Updates
  7.11.6 Vial Competitive Strengths & Weaknesses
7.12 Machaon Diagnostics
  7.12.1 Machaon Diagnostics Details
  7.12.2 Machaon Diagnostics Major Business
  7.12.3 Machaon Diagnostics Rare Disease CRO Service Product and Services
  7.12.4 Machaon Diagnostics Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Machaon Diagnostics Recent Developments/Updates
  7.12.6 Machaon Diagnostics Competitive Strengths & Weaknesses
7.13 Caidya
  7.13.1 Caidya Details
  7.13.2 Caidya Major Business
  7.13.3 Caidya Rare Disease CRO Service Product and Services
  7.13.4 Caidya Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Caidya Recent Developments/Updates
  7.13.6 Caidya Competitive Strengths & Weaknesses
7.14 Simbec Orion
  7.14.1 Simbec Orion Details
  7.14.2 Simbec Orion Major Business
  7.14.3 Simbec Orion Rare Disease CRO Service Product and Services
  7.14.4 Simbec Orion Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Simbec Orion Recent Developments/Updates
  7.14.6 Simbec Orion Competitive Strengths & Weaknesses
7.15 Linical
  7.15.1 Linical Details
  7.15.2 Linical Major Business
  7.15.3 Linical Rare Disease CRO Service Product and Services
  7.15.4 Linical Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 Linical Recent Developments/Updates
  7.15.6 Linical Competitive Strengths & Weaknesses
7.16 MMS
  7.16.1 MMS Details
  7.16.2 MMS Major Business
  7.16.3 MMS Rare Disease CRO Service Product and Services
  7.16.4 MMS Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.16.5 MMS Recent Developments/Updates
  7.16.6 MMS Competitive Strengths & Weaknesses
7.17 Veristat
  7.17.1 Veristat Details
  7.17.2 Veristat Major Business
  7.17.3 Veristat Rare Disease CRO Service Product and Services
  7.17.4 Veristat Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.17.5 Veristat Recent Developments/Updates
  7.17.6 Veristat Competitive Strengths & Weaknesses
7.18 Celero
  7.18.1 Celero Details
  7.18.2 Celero Major Business
  7.18.3 Celero Rare Disease CRO Service Product and Services
  7.18.4 Celero Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.18.5 Celero Recent Developments/Updates
  7.18.6 Celero Competitive Strengths & Weaknesses
7.19 Rho
  7.19.1 Rho Details
  7.19.2 Rho Major Business
  7.19.3 Rho Rare Disease CRO Service Product and Services
  7.19.4 Rho Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.19.5 Rho Recent Developments/Updates
  7.19.6 Rho Competitive Strengths & Weaknesses
7.20 PROMETRIKA
  7.20.1 PROMETRIKA Details
  7.20.2 PROMETRIKA Major Business
  7.20.3 PROMETRIKA Rare Disease CRO Service Product and Services
  7.20.4 PROMETRIKA Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.20.5 PROMETRIKA Recent Developments/Updates
  7.20.6 PROMETRIKA Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Rare Disease CRO Service Industry Chain
8.2 Rare Disease CRO Service Upstream Analysis
8.3 Rare Disease CRO Service Midstream Analysis
8.4 Rare Disease CRO Service Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Rare Disease CRO Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Rare Disease CRO Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Rare Disease CRO Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Rare Disease CRO Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Rare Disease CRO Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Rare Disease CRO Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Rare Disease CRO Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Rare Disease CRO Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Rare Disease CRO Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Rare Disease CRO Service Players in 2022
Table 12. World Rare Disease CRO Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Rare Disease CRO Service Company Evaluation Quadrant
Table 14. Head Office of Key Rare Disease CRO Service Player
Table 15. Rare Disease CRO Service Market: Company Product Type Footprint
Table 16. Rare Disease CRO Service Market: Company Product Application Footprint
Table 17. Rare Disease CRO Service Mergers & Acquisitions Activity
Table 18. United States VS China Rare Disease CRO Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Rare Disease CRO Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Rare Disease CRO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Rare Disease CRO Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Rare Disease CRO Service Revenue Market Share (2018-2023)
Table 23. China Based Rare Disease CRO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Rare Disease CRO Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Rare Disease CRO Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Rare Disease CRO Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Rare Disease CRO Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Rare Disease CRO Service Revenue Market Share (2018-2023)
Table 29. World Rare Disease CRO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Rare Disease CRO Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Rare Disease CRO Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Rare Disease CRO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Rare Disease CRO Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Rare Disease CRO Service Market Size by Application (2024-2029) & (USD Million)
Table 35. Precision for Medicine Basic Information, Area Served and Competitors
Table 36. Precision for Medicine Major Business
Table 37. Precision for Medicine Rare Disease CRO Service Product and Services
Table 38. Precision for Medicine Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Precision for Medicine Recent Developments/Updates
Table 40. Precision for Medicine Competitive Strengths & Weaknesses
Table 41. Orphan-Reach Basic Information, Area Served and Competitors
Table 42. Orphan-Reach Major Business
Table 43. Orphan-Reach Rare Disease CRO Service Product and Services
Table 44. Orphan-Reach Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Orphan-Reach Recent Developments/Updates
Table 46. Orphan-Reach Competitive Strengths & Weaknesses
Table 47. Medpace Basic Information, Area Served and Competitors
Table 48. Medpace Major Business
Table 49. Medpace Rare Disease CRO Service Product and Services
Table 50. Medpace Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Medpace Recent Developments/Updates
Table 52. Medpace Competitive Strengths & Weaknesses
Table 53. Parexel Basic Information, Area Served and Competitors
Table 54. Parexel Major Business
Table 55. Parexel Rare Disease CRO Service Product and Services
Table 56. Parexel Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Parexel Recent Developments/Updates
Table 58. Parexel Competitive Strengths & Weaknesses
Table 59. PPD Basic Information, Area Served and Competitors
Table 60. PPD Major Business
Table 61. PPD Rare Disease CRO Service Product and Services
Table 62. PPD Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. PPD Recent Developments/Updates
Table 64. PPD Competitive Strengths & Weaknesses
Table 65. Worldwide Clinical Trials Basic Information, Area Served and Competitors
Table 66. Worldwide Clinical Trials Major Business
Table 67. Worldwide Clinical Trials Rare Disease CRO Service Product and Services
Table 68. Worldwide Clinical Trials Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Worldwide Clinical Trials Recent Developments/Updates
Table 70. Worldwide Clinical Trials Competitive Strengths & Weaknesses
Table 71. AllStripes Basic Information, Area Served and Competitors
Table 72. AllStripes Major Business
Table 73. AllStripes Rare Disease CRO Service Product and Services
Table 74. AllStripes Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. AllStripes Recent Developments/Updates
Table 76. AllStripes Competitive Strengths & Weaknesses
Table 77. LabCorp Basic Information, Area Served and Competitors
Table 78. LabCorp Major Business
Table 79. LabCorp Rare Disease CRO Service Product and Services
Table 80. LabCorp Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. LabCorp Recent Developments/Updates
Table 82. LabCorp Competitive Strengths & Weaknesses
Table 83. Novotech Basic Information, Area Served and Competitors
Table 84. Novotech Major Business
Table 85. Novotech Rare Disease CRO Service Product and Services
Table 86. Novotech Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Novotech Recent Developments/Updates
Table 88. Novotech Competitive Strengths & Weaknesses
Table 89. Syneos Health Basic Information, Area Served and Competitors
Table 90. Syneos Health Major Business
Table 91. Syneos Health Rare Disease CRO Service Product and Services
Table 92. Syneos Health Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Syneos Health Recent Developments/Updates
Table 94. Syneos Health Competitive Strengths & Weaknesses
Table 95. Vial Basic Information, Area Served and Competitors
Table 96. Vial Major Business
Table 97. Vial Rare Disease CRO Service Product and Services
Table 98. Vial Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Vial Recent Developments/Updates
Table 100. Vial Competitive Strengths & Weaknesses
Table 101. Machaon Diagnostics Basic Information, Area Served and Competitors
Table 102. Machaon Diagnostics Major Business
Table 103. Machaon Diagnostics Rare Disease CRO Service Product and Services
Table 104. Machaon Diagnostics Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Machaon Diagnostics Recent Developments/Updates
Table 106. Machaon Diagnostics Competitive Strengths & Weaknesses
Table 107. Caidya Basic Information, Area Served and Competitors
Table 108. Caidya Major Business
Table 109. Caidya Rare Disease CRO Service Product and Services
Table 110. Caidya Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Caidya Recent Developments/Updates
Table 112. Caidya Competitive Strengths & Weaknesses
Table 113. Simbec Orion Basic Information, Area Served and Competitors
Table 114. Simbec Orion Major Business
Table 115. Simbec Orion Rare Disease CRO Service Product and Services
Table 116. Simbec Orion Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Simbec Orion Recent Developments/Updates
Table 118. Simbec Orion Competitive Strengths & Weaknesses
Table 119. Linical Basic Information, Area Served and Competitors
Table 120. Linical Major Business
Table 121. Linical Rare Disease CRO Service Product and Services
Table 122. Linical Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Linical Recent Developments/Updates
Table 124. Linical Competitive Strengths & Weaknesses
Table 125. MMS Basic Information, Area Served and Competitors
Table 126. MMS Major Business
Table 127. MMS Rare Disease CRO Service Product and Services
Table 128. MMS Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. MMS Recent Developments/Updates
Table 130. MMS Competitive Strengths & Weaknesses
Table 131. Veristat Basic Information, Area Served and Competitors
Table 132. Veristat Major Business
Table 133. Veristat Rare Disease CRO Service Product and Services
Table 134. Veristat Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Veristat Recent Developments/Updates
Table 136. Veristat Competitive Strengths & Weaknesses
Table 137. Celero Basic Information, Area Served and Competitors
Table 138. Celero Major Business
Table 139. Celero Rare Disease CRO Service Product and Services
Table 140. Celero Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Celero Recent Developments/Updates
Table 142. Celero Competitive Strengths & Weaknesses
Table 143. Rho Basic Information, Area Served and Competitors
Table 144. Rho Major Business
Table 145. Rho Rare Disease CRO Service Product and Services
Table 146. Rho Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Rho Recent Developments/Updates
Table 148. PROMETRIKA Basic Information, Area Served and Competitors
Table 149. PROMETRIKA Major Business
Table 150. PROMETRIKA Rare Disease CRO Service Product and Services
Table 151. PROMETRIKA Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Rare Disease CRO Service Upstream (Raw Materials)
Table 153. Rare Disease CRO Service Typical Customers

LIST OF FIGURE

Figure 1. Rare Disease CRO Service Picture
Figure 2. World Rare Disease CRO Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Rare Disease CRO Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Rare Disease CRO Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Rare Disease CRO Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Rare Disease CRO Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Rare Disease CRO Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Rare Disease CRO Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Rare Disease CRO Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Rare Disease CRO Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Rare Disease CRO Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Rare Disease CRO Service Revenue (2018-2029) & (USD Million)
Figure 13. Rare Disease CRO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Rare Disease CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Rare Disease CRO Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Rare Disease CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Rare Disease CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Rare Disease CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Rare Disease CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Rare Disease CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Rare Disease CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Rare Disease CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Rare Disease CRO Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Rare Disease CRO Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Rare Disease CRO Service Markets in 2022
Figure 27. United States VS China: Rare Disease CRO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Rare Disease CRO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Rare Disease CRO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Rare Disease CRO Service Market Size Market Share by Type in 2022
Figure 31. Drug Development Strategy
Figure 32. Clinical Trial Management
Figure 33. World Rare Disease CRO Service Market Size Market Share by Type (2018-2029)
Figure 34. World Rare Disease CRO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Rare Disease CRO Service Market Size Market Share by Application in 2022
Figure 36. Cardiovascular
Figure 37. Neuroscience
Figure 38. Ophthalmology
Figure 39. Others
Figure 40. Rare Disease CRO Service Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source


More Publications